JP2022540854A5 - - Google Patents

Info

Publication number
JP2022540854A5
JP2022540854A5 JP2022501259A JP2022501259A JP2022540854A5 JP 2022540854 A5 JP2022540854 A5 JP 2022540854A5 JP 2022501259 A JP2022501259 A JP 2022501259A JP 2022501259 A JP2022501259 A JP 2022501259A JP 2022540854 A5 JP2022540854 A5 JP 2022540854A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
ibuprofen
pharmaceutically acceptable
composition according
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022501259A
Other languages
English (en)
Japanese (ja)
Other versions
JP7656339B2 (ja
JP2022540854A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/069306 external-priority patent/WO2021005129A1/en
Publication of JP2022540854A publication Critical patent/JP2022540854A/ja
Publication of JP2022540854A5 publication Critical patent/JP2022540854A5/ja
Application granted granted Critical
Publication of JP7656339B2 publication Critical patent/JP7656339B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022501259A 2019-07-09 2020-07-08 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ Active JP7656339B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382583.3 2019-07-09
EP19382583 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (3)

Publication Number Publication Date
JP2022540854A JP2022540854A (ja) 2022-09-20
JP2022540854A5 true JP2022540854A5 (enExample) 2023-07-19
JP7656339B2 JP7656339B2 (ja) 2025-04-03

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501259A Active JP7656339B2 (ja) 2019-07-09 2020-07-08 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ

Country Status (21)

Country Link
US (1) US12514833B2 (enExample)
EP (1) EP3996699B1 (enExample)
JP (1) JP7656339B2 (enExample)
CN (1) CN114080221B (enExample)
AU (1) AU2020309160B2 (enExample)
BR (1) BR112022000242A2 (enExample)
CA (1) CA3145632C (enExample)
DK (1) DK3996699T3 (enExample)
ES (1) ES2952013T3 (enExample)
FI (1) FI3996699T3 (enExample)
HR (1) HRP20230677T1 (enExample)
HU (1) HUE062529T2 (enExample)
MA (1) MA56341B1 (enExample)
MD (1) MD3996699T2 (enExample)
MX (1) MX2022000373A (enExample)
MY (1) MY207573A (enExample)
PL (1) PL3996699T3 (enExample)
PT (1) PT3996699T (enExample)
RS (1) RS64500B1 (enExample)
SI (1) SI3996699T1 (enExample)
WO (1) WO2021005129A1 (enExample)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
PL348808A1 (en) 1998-11-02 2002-06-17 Ortho Mcneil Pharm Inc Analgesic regimen
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
DE60114249T2 (de) 2001-11-02 2006-05-18 Cumberland Pharmaceuticals Inc., Nashville Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP1558234B1 (en) 2002-10-25 2007-05-23 Dompé S.P.A. Painless injectable compositions containing salt of 2-arylpropionic acids
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
EP2381937A2 (en) 2008-12-31 2011-11-02 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
KR20140014350A (ko) 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8735452B2 (en) 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
MX2010004974A (es) 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
CA2833307C (en) 2011-04-12 2018-01-23 Revogenex Inc. Intravenous administration of tramadol
US9351926B2 (en) 2012-02-20 2016-05-31 Pharmaceutical Solutions Industry Ltd. Ibuprofen intravenous infusion
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
BR112016023628A2 (pt) * 2014-04-10 2018-05-15 Charleston Laboratories Inc composições farmacêuticas.

Similar Documents

Publication Publication Date Title
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
JP2018513188A5 (enExample)
JP6353577B2 (ja) 組み合わせ組成物
JP2022537551A5 (enExample)
JP2005515966A5 (enExample)
JP2009102342A5 (enExample)
JP2022545156A5 (enExample)
JP2008535867A5 (enExample)
JP2014515373A5 (enExample)
JP2023552700A5 (enExample)
JP2023535744A5 (enExample)
JP2017533211A5 (enExample)
JP2023500032A5 (enExample)
JP2024534427A5 (enExample)
JP2019501881A5 (enExample)
JP2010524882A5 (enExample)
JP2008533127A5 (enExample)
JP2020510043A5 (enExample)
JP2016505050A5 (enExample)
JP2005512946A5 (enExample)
JP2004525143A5 (enExample)
IL272834B1 (en) Compositions of amantadine, their preparation, and methods of use
JP2022540854A5 (enExample)
JP2023510965A5 (enExample)
BR112020017773A2 (pt) Composição farmacêutica compreendendo polmacoxibe e pregabalina para tratamento de dor